SynthesisFrontiers in immunology2026

The efficacy and safety of pembrolizumab in the treatment of HER2-negative advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis of emerging clinical data.

Ying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.